Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -380.85% is 77% below its 4-year average of -215.31%, near the low end of its 4-year range (-1970.11%–11195.72%).
123.53% below its 12-month average of 1618.46%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 11195.72%.
OPERATING MARGIN
-380.85%
OPERATING MARGIN AVG TTM
1618.46%
OPERATING MARGIN AVG 3Y
-196.24%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-123.53%
CURRENT VS 3Y AVG
-94.08%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Metagenomi, Inc. Common Stock
Market Cap
$40.28M
Operating Margin
-380.85%
TTM Avg
1618.46%
3Y Avg
-196.24%
5Y Avg
N/A
Market Cap
$39.23M
Operating Margin
0.00%
TTM Avg
-13830.82%
3Y Avg
-69500.82%
5Y Avg
-46675.05%
Market Cap
$41.90M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$41.79M
Operating Margin
-90.49%
TTM Avg
-103.23%
3Y Avg
-126.36%
5Y Avg
-149.14%
Market Cap
$38.52M
Operating Margin
1.17%
TTM Avg
-3.67%
3Y Avg
-2.94%
5Y Avg
-1.63%
Market Cap
$37.23M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-324.45%
Market Cap
$36.59M
Operating Margin
-991.71%
TTM Avg
-581.79%
3Y Avg
-302.08%
5Y Avg
-237.73%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $40.28M | -380.85% | 1618.46% | -196.24% | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $39.23M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
| Nephros, Inc. (NEPH)vs › | $39.21M | 7.92% | 3.07% | -12.13% | -21.71% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.90M | 0.00% | 0.00% | 0.00% | 0.00% |
| CVRx, Inc. (CVRX)vs › | $41.79M | -90.49% | -103.23% | -126.36% | -149.14% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 1.17% | -3.67% | -2.94% | -1.63% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.23M | 0.00% | 0.00% | 0.00% | -324.45% |
| iTonic Holdings Ltd. (ITOC)vs › | $36.59M | -991.71% | -581.79% | -302.08% | -237.73% |
| DocGo Inc. (DCGO)vs › | $36.48M | -27.67% | -11.51% | -3.91% | -4.42% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.16M | -1.45% | 4.45% | -26.46% | -35.98% |
Gross Margin
74.3%
Operating Margin
-380.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 11195.72% |
| 2026-03-31 | -1970.11% |
| 2025-12-31 | -623.04% |
| 2025-09-30 | -263.76% |
| 2025-06-30 | -246.53% |
| 2025-03-31 | -674.10% |
| 2024-12-31 | -214.51% |
| 2024-09-30 | -194.40% |
| 2024-06-30 | -84.28% |
| 2024-03-31 | -260.17% |
| 2023-12-31 | -162.88% |
| 2023-09-30 | -181.15% |
| 2023-06-30 | -158.45% |
| 2023-03-31 | -207.21% |
| 2022-12-31 | -281.79% |
| 2022-09-30 | -221.39% |
| 2022-06-30 | -268.93% |
| 2022-03-31 | -268.93% |
